Taro Pharm

TARO NYSE
83.92
-1.36
-1.59%
Closed 16:00 06/24 EDT
Open
84.93
Prev Close
85.28
High
85.59
Low
83.00
Volume
242.48K
Avg Vol (3M)
72.16K
52 Week High
117.76
52 Week Low
76.93
% Turnover
0.63%
Market Cap
3.23B
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Taro Pharm TARO stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets over 200 pharmaceutical products in over 25 countries. The Company's owned product brands include Rokacet, with generic names, such as acetaminophen, codeine and caffeine; Topicort, with the generic name, desoximetasone; Etopan, with the generic name etodolac, and Ovide, with the generic name, malathion, among others. The Company's other generic products include acetazolamide, adapalene, alclometasone dipropionate, amiodarone hydrochloride, ammonium lactate, augmented betamethasone dipropionate, cetirizine hydrochloride, clobetasol propionate, clomipramine hydrochloride, clorazepate dipotassium, fluorouracil, ketoconazole, metronidazole, mupirocin and warfarin sodium, among others.
MORE >

Recently

Name
Price
%Change